Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
SO-29: Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: Prevalence and correlation between DPYD-genotype mutations and P-uracil concentrations
